CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene-gene interactions

被引:42
作者
Vineis, P
Veglia, F
Anttila, S
Benhamou, S
Clapper, ML
Dolzan, V
Ryberg, D
Hirvonen, A
Kremers, P
Le Marchand, L
Pastorelli, R
Rannug, A
Romkes, M
Schoket, B
Strange, RC
Garte, S
Taioli, E
机构
[1] Univ London Imperial Coll Sci Technol & Med, London, England
[2] Univ Turin, Turin, Italy
[3] Inst Sci Interchange Fdn, Turin, Italy
[4] Finnish Inst Occupat Hlth, Helsinki, Finland
[5] Inst Gustave Roussy, Villejuif, France
[6] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[7] Univ Ljubljana, Ljubljana, Slovenia
[8] Natl Inst Occupat Hlth, Oslo, Norway
[9] Finnish Inst Occupat Hlth, Helsinki, Finland
[10] Inst Pathol B23, Liege, Belgium
[11] Univ Hawaii, Honolulu, HI 96822 USA
[12] Ist Ric Farmacol Mario Negri, Milan, Italy
[13] Karolinska Inst, Stockholm, Sweden
[14] Univ Pittsburgh, Pittsburgh, PA USA
[15] Jozsef Fodor Natl Ctr Publ Hlth, Budapest, Hungary
[16] Keele Univ, Stoke On Trent, Staffs, England
[17] Genet Res Inst, Milan, Italy
[18] Osped Maggiore, IRCCS, Milan, Italy
关键词
gene-gene interactions; CYP1A1; GSTM1; GSTT1; lung cancer; pooled analysis;
D O I
10.1080/13547500400011070
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Gene - environment interactions have been extensively studied in lung cancer. It is likely that several genetic polymorphisms cooperate in increasing the individual risk. Therefore, the study of gene - gene interactions might be important to identify high-susceptibility subgroups. GSEC is an initiative aimed at collecting available data sets on metabolic polymorphisms and the risks of cancer at several sites and performing pooled analyses of the original data. Authors of published papers have provided original data sets. The present paper refers to gene - gene interactions in lung cancer and considers three polymorphisms in three metabolic genes: CYP1A1, GSTM1 and GSTT1. The present analyses compare the gene - gene interactions of the CYP1A1* 2A, GSTM1 and GSTT1 polymorphisms from studies on lung cancer conducted in Europe and the USA between 1991 and 2000. Only Caucasians have been included. The data set includes 1466 cases and 1488 controls. The only clear-cut association was found with CYP1A1* 2A. This association remained unchanged after stratification by polymorphisms in other genes (with an odds ratio [OR] of approximately 2.5), except when interaction with GSTM1 was considered. When the OR for CYP1A1* 2A was stratified according to the GSTM1 genotype, the OR was increased only among the subjects who had the null ( homozygous deletion) GSTM1 genotype ( OR = 2.8, 95% CI = 0.9 - 8.4). The odds ratio for the interactive term ( CYP1A1* 2A by GSTM1) in logistic regression was 2.7 (95% CI = 0.5 - 15.3). An association between lung cancer and the homozygous CYP1A1* 2A genotype is confirmed. An apparent and biologically plausible interaction is suggested between this genotype and GSTM1.
引用
收藏
页码:298 / 305
页数:8
相关论文
共 37 条
  • [1] GENETIC SUSCEPTIBILITY TO LUNG-CANCER WITH SPECIAL EMPHASIS ON CYP1A1 AND GSTM1 - A STUDY ON HOST FACTORS IN RELATION TO AGE AT ONSET, GENDER AND HISTOLOGICAL CANCER TYPES
    ALEXANDRIE, AK
    SUNDBERG, MI
    SEIDEGARD, J
    TORNLING, G
    RANNUG, A
    [J]. CARCINOGENESIS, 1994, 15 (09) : 1785 - 1790
  • [2] CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung:: comparison with aromatic/hydrophobic adduct formation
    Alexandrov, K
    Cascorbi, I
    Rojas, M
    Bouvier, G
    Kriek, E
    Bartsch, H
    [J]. CARCINOGENESIS, 2002, 23 (12) : 1969 - 1977
  • [3] ANTTILA S, 1995, CANCER RES, V55, P3305
  • [4] CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor
    Anttila, S
    Tuominen, P
    Hirvonen, A
    Nurminen, M
    Karjalainen, A
    Hankinson, O
    Elovaara, E
    [J]. PHARMACOGENETICS, 2001, 11 (06): : 501 - 509
  • [5] Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk
    Benhamou, S
    Lee, WJ
    Alexandrie, AK
    Boffetta, P
    Bouchardy, C
    Butkiewicz, D
    Brockmöller, J
    Clapper, ML
    Daly, A
    Dolzan, V
    Ford, J
    Gaspari, L
    Haugen, A
    Hirvonen, A
    Husgafvel-Pursiainen, K
    Ingelman-Sundberg, M
    Kalina, I
    Kihara, M
    Kremers, P
    Le Marchand, L
    London, SJ
    Nazar-Stewart, V
    Onon-Kihara, M
    Rannug, A
    Romkes, M
    Ryberg, D
    Seidegard, J
    Shields, P
    Strange, RC
    Stücker, I
    To-Figueras, J
    Brennan, P
    Taioli, E
    [J]. CARCINOGENESIS, 2002, 23 (08) : 1343 - 1350
  • [6] CYP1A1 genetic polymorphisms, tobacco smoking and lung cancer risk in a French Caucasian population
    Bouchardy, C
    Wikman, H
    Benhamou, S
    Hirvonen, A
    Dayer, P
    HusgafvelPursiainen, K
    [J]. BIOMARKERS, 1997, 2 (02) : 131 - 134
  • [7] BRESLOW NE, 1980, SCI PUBL IARC, V32
  • [8] GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland:: correlation with lung DNA adduct levels
    Butkiewicz, D
    Cole, KJ
    Phillips, DH
    Harris, CC
    Chorazy, M
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 1999, 8 (04) : 315 - 323
  • [9] Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: Studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers
    Deakin, M
    Elder, J
    Hendrickse, C
    Peckham, D
    Baldwin, D
    Pantin, C
    Wild, N
    Leopard, P
    Bell, DA
    Jones, P
    Duncan, H
    Brannigan, K
    Alldersea, J
    Fryer, AA
    Strange, RC
    [J]. CARCINOGENESIS, 1996, 17 (04) : 881 - 884
  • [10] Genetic polymorphism of xenobiotic metabolising enzymes in Slovenian lung cancer patients
    Dolzan, V
    Rudolf, Z
    Breskvar, K
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2000, 439 (03): : R29 - R30